|
Liver carcinoma
|
0.340 |
AlteredExpression
|
disease |
BEFREE |
Analysis using the Oncomine database showed that NCAPG was upregulated in HCC and immunohistochemistry and Western blot assays showed it was upregulated in both HCC tissues and HCC cell lines.
|
31802891 |
2019 |
|
Liver carcinoma
|
0.340 |
AlteredExpression
|
disease |
BEFREE |
There was a negative correlation between miR-181c expression and NCAPG in HCC tissue samples.
|
31114379 |
2019 |
|
Liver carcinoma
|
0.340 |
Biomarker
|
disease |
BEFREE |
Therefore, NCAPG may provide a promising novel therapeutic target for the treatment of advanced HCC in the future.
|
29046167 |
2018 |
|
Liver carcinoma
|
0.340 |
AlteredExpression
|
disease |
BEFREE |
NCAPG protein expression in human HCC and paracancerous hepatic tissues were examined using immunohistochemistry, and NCAPG mRNA expression in HCC cell lines were quantified using quantitative RT-PCR.
|
30089216 |
2018 |
|
Liver carcinoma
|
0.340 |
Biomarker
|
disease |
CTD_human |
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
|
28284560 |
2017 |
|
Colorectal Carcinoma
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
|
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analyses of diverse populations improves discovery for complex traits.
|
31217584 |
2019 |
|
Intelligence
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence.
|
29942086 |
2018 |
|
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of genome-wide association studies of adult height in East Asians identifies 17 novel loci.
|
25429064 |
2015 |
|
Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry.
|
21998595 |
2011 |
|
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Knockdown of NCAPG inhibited cancer cell aggressiveness.
|
29608247 |
2018 |
|
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
Knockdown of NCAPG inhibited cancer cell aggressiveness.
|
29608247 |
2018 |
|
Malignant Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
This mitosis-related expression suggests hCAP-G as a possible proliferation marker and a potential prognostic indicator in cancer.
|
10910072 |
2000 |
|
Primary malignant neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
This mitosis-related expression suggests hCAP-G as a possible proliferation marker and a potential prognostic indicator in cancer.
|
10910072 |
2000 |
|
Triple Negative Breast Neoplasms
|
0.010 |
Biomarker
|
disease |
BEFREE |
These findings suggested that NCAPG and ABCA9 may be the key genes of TNBC.
|
31081967 |
2019 |
|
Triple-Negative Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These findings suggested that NCAPG and ABCA9 may be the key genes of TNBC.
|
31081967 |
2019 |
|
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RT-qPCR results showed that hsa-miR-148a-3p, hsa-miR-193b-3p, and hsa-miR-1179 were downregulated, and NCAPG and KNL1 were upregulated in GC tissues; this is consistent with our bioinformatics-predicted results.
|
30390708 |
2018 |
|
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Tetracycline-inducible shRNA knockdown of NCAPG inhibits tumor growth of HCC cells in vivo.
|
29046167 |
2018 |
|
Adenocarcinoma of lung (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
In our study, we identified eight candidate genes (DLGAP5, KIF11, RAD51AP1, CCNB1, AURKA, CDC6, OIP5 and NCAPG) closely related to survival in LUAD.
|
30237740 |
2018 |
|
Childhood Hepatocellular Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.
|
29046167 |
2018 |
|
Adult Hepatocellular Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.
|
29046167 |
2018 |
|
Malignant neoplasm of liver
|
0.010 |
Biomarker
|
disease |
BEFREE |
Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.
|
29046167 |
2018 |
|
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RT-qPCR results showed that hsa-miR-148a-3p, hsa-miR-193b-3p, and hsa-miR-1179 were downregulated, and NCAPG and KNL1 were upregulated in GC tissues; this is consistent with our bioinformatics-predicted results.
|
30390708 |
2018 |
|
Hormone refractory prostate cancer
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of NCAPG was detected in CRPC clinical specimens and was significantly associated with shorter disease-free survival and advanced clinical stage.
|
29608247 |
2018 |
|
Dwarfism
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Finally, we report a catalog of regions of elevated genetic differentiation between dwarf and normal-size rabbits, including LCORL-NCAPG, STC2, HOXD cluster, and IGF2BP2 Levels and patterns of genetic diversity at the LCORL-NCAPG locus further suggest that small size in dwarf breeds was enhanced by crosses with wild rabbits.
|
27986804 |
2017 |